Industry 4.0 requires comprehensive data collection in order to control highly automated process sequences in complex production environments. One example is the cultivation of living cells. But digitalizing and networking biotech production equipment is a huge challenge: relevant standards have yet to be established, and biology has a dynamic all its own. Using fully automated equipment for producing stem cells, Fraunhofer researchers have managed to adjust the process control to cell growth – delivering an adaptive system that is suitable for use in a number of sectors.
If you think of a robot, you’re probably picturing C-3PO, Ultron or Wall-E. But what if robots don’t need to be big, humanoid and upright? What if they aren’t even made of metal?
Physicians at Upstate Medical University in Syracuse describe in the December issue of Urology the first case ever in which doctors used minimally invasive robotic surgery to perform a radical nephrectomy (removal of entire kidney) with a level III inferior vena cava thrombectomy (removal of a tumor from the largest vein that carries blood to the heart).
Bioengineering researcher Keith Markolf frequently gets this question when colleagues visiting from around the world first lay eyes on the 8-foot-tall, pumpkin-orange behemoth dominating the UCLA Orthopaedic Biomechanics Laboratory at UCLA’s Rehabilitation Center.
Researchers from the MIRA research centre, together with the VUmc, TU Delft and the Radboud umc, have developed the A-Gear: a robotic arm that can support the daily activities of people suffering the muscular disease Duchenne Muscular Dystrophy. They recently put the final touches to the first prototype for a discreet, body-connected support aid that can be worn under the clothing and that can support independent operation of the arm during important daily activities.
Researchers from UPM have developed an intelligent robotic system that improves the recovery of patients with shoulder injuries, a diseases that cause a high rate of sick leave.
Mayo Clinic has added robots in its fight against Clostridium difficile (C-diff) bacteria.
A team of European researchers, including an UPM group, is currently working on the development of training technologies and surgical evaluation based on laparoscopic videos assessments.
Ekso Bionics Holdings, Inc., a leading global robotic exoskeleton company, announced a new randomized comparative clinical trial is currently underway in Europe. The trial is called “The MOST Study” (Mobility improved after stroke when a robotic device was used in comparison to physical therapy) and is being initialized by Professor Dr. med. F. Hamzei, MD, MHBA, Chief physician of Department of Neurological Rehabilitation, Moritz Klinik. This study is investigating the impact of gait training with the Ekso GT™ on functional independence of 80 patients with impaired gait as a consequence of stroke, when compared to conventional physiotherapy alone.
Patients who have lost their hand functions due to injuries or nerve-related conditions, such as stroke and muscular dystrophy, now have a chance of restoring their hand movements by using a new lightweight and smart rehabilitation device called EsoGlove developed by a research team from the National University of Singapore (NUS).
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.